CNCCENTENE CORP

NYSE centene.com


$ 74.81 $ 0.48 (0.65 %)    

Friday, 03-May-2024 15:59:52 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 74.81
$ 74.43
$ 0.00 x 0
$ 0.00 x 0
$ 73.79 - $ 75.06
$ 60.83 - $ 81.42
4,706,732
na
40.25B
$ 0.93
$ 14.72
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-20-2024 12-31-2023 10-K
3 10-23-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-25-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 10-25-2022 09-30-2022 10-Q
8 07-26-2022 06-30-2022 10-Q
9 04-26-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 10-26-2021 09-30-2021 10-Q
12 07-26-2021 06-30-2021 10-Q
13 04-27-2021 03-31-2021 10-Q
14 02-22-2021 12-31-2020 10-K
15 10-27-2020 09-30-2020 10-Q
16 07-28-2020 06-30-2020 10-Q
17 04-28-2020 03-31-2020 10-Q
18 02-18-2020 12-31-2019 10-K
19 10-22-2019 09-30-2019 10-Q
20 07-23-2019 06-30-2019 10-Q
21 04-23-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 10-23-2018 09-30-2018 10-Q
24 07-24-2018 06-30-2018 10-Q
25 04-24-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 10-24-2017 09-30-2017 10-Q
28 07-25-2017 06-30-2017 10-Q
29 04-25-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-25-2016 09-30-2016 10-Q
32 07-26-2016 06-30-2016 10-Q
33 04-26-2016 03-31-2016 10-Q
34 02-22-2016 12-31-2015 10-K
35 10-27-2015 09-30-2015 10-Q
36 07-28-2015 06-30-2015 10-Q
37 04-28-2015 03-31-2015 10-Q
38 02-23-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-22-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 4-stocks-that-are-looking-like-a-great-value-right-now

These four companies appear to be a good deal based on future earnings expectations and trading at a low price/earnings (P/E) r...

 barclays-maintains-overweight-on-centene-raises-price-target-to-104

Barclays analyst Andrew Mok maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $101 to $104.

 wellcare-the-medicare-business-of-centene-corp-and-wellvana-announce-partnership-to-expand-patient-centered-primary-care-for-benefit-of-medicare-advantage-members-in-georgia-tennessee-and-texas

Wellcare, the Medicare business of Centene Corporation (NYSE:CNC), and Wellvana, a value-based care physician enablement compan...

 deutsche-bank-maintains-hold-on-centene-raises-price-target-to-82

Deutsche Bank analyst George Hill maintains Centene (NYSE:CNC) with a Hold and raises the price target from $81 to $82.

 oppenheimer-maintains-outperform-on-centene-maintains-110-price-target

Oppenheimer analyst Michael Wiederhorn maintains Centene (NYSE:CNC) with a Outperform and maintains $110 price target.

 centenes-first-quarter-surge-sales-soar-to-4041b-exceeding-expectations-whats-next-for-the-healthcare-company

Centene outperforms expectations with $40.41 billion in Q1 sales, driven by robust growth in premium revenues and steady member...

 centene-q1-2024-adj-eps-226-beats-208-estimate-sales-40407b-beat-36536b-estimate

Centene (NYSE:CNC) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $2.08 by 8.65 pe...

 stocks-grapple-with-geopolitical-pressures-gold-eyes-2400-bitcoin-falls-below-62000-whats-driving-markets-tuesday

Investors remain on edge as geopolitics continue to shape market trends, with Israel mulling a response to Iran while the U.S. ...

 wall-street-braces-for-mixed-open-as-middle-east-tensions-offset-earnings-optimism-analyst-points-to-silver-lining-in-rally-break

Earnings optimism may partly offset worries concerning rising bond yields and the volatile geopolitical situation in the Middle...

 see-how-floridas-much-awaited-medicaid-re-procurement-awards-impact-centene-humana-molina

Florida announces Medicaid contract awards to Centene, Elevance Health, and Humana, sidelining UnitedHealth, CVS Health, and Mo...

 cisco-to-rally-around-24-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 wells-fargo-maintains-overweight-on-centene-raises-price-target-to-93

Wells Fargo analyst Stephen Baxter maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $89 to $93.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION